Compare RVLV & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVLV | CRNX |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 4.5B |
| IPO Year | 2018 | 2018 |
| Metric | RVLV | CRNX |
|---|---|---|
| Price | $22.90 | $37.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | $29.75 | ★ $74.78 |
| AVG Volume (30 Days) | ★ 1.4M | 872.2K |
| Earning Date | 05-27-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.64 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $1,225,682,000.00 | $1,039,000.00 |
| Revenue This Year | $10.96 | $730.30 |
| Revenue Next Year | $8.01 | $179.48 |
| P/E Ratio | $26.52 | ★ N/A |
| Revenue Growth | ★ 8.48 | N/A |
| 52 Week Low | $16.80 | $24.10 |
| 52 Week High | $31.68 | $57.99 |
| Indicator | RVLV | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 37.52 | 28.54 |
| Support Level | $20.05 | $33.23 |
| Resistance Level | $24.54 | $45.32 |
| Average True Range (ATR) | 1.31 | 1.82 |
| MACD | -0.07 | -0.21 |
| Stochastic Oscillator | 17.44 | 19.55 |
Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.